Theranostics: alphas or betas?
This ENETS webinar provides an introduction to alpha- and beta-emitting peptide receptor radionuclide therapy (PRRT) in the management of neuroendocrine neoplasms (NENs), with a particular focus on emerging alpha-emitting approaches.
The programme covers the fundamentals of alpha and beta emitters, reviews the scientific evidence for alpha-emitting PRRT, and explores its potential place in the treatment sequence. An interactive faculty discussion will bring these topics together and consider their potential clinical implications.
This free webinar is open to all healthcare professionals and is particularly suited to those with a basic understanding of NENs who would like an introduction to this topic. Advance registration is required. Please use the button below to register for the Zoom session.
Date:
27.01.2027
Time:
18:00 - 19:10 CET
Educational Level:
Agenda:
Moderator: Arthur Braat (NED)
18:00 – 18:05 Opening comments – Arthur Braat (NED)
18:05 – 18:20 The basics: alpha and beta emitters – Joachim Nilsson (SWE)
18:20 – 18:35 Update on scientific evidence for alpha-emitting PRRT – Elisabetta Perrone (ITA)
18:35 – 18:50 Where might alpha-emitting PRRT fit in the treatment sequence? – Thor Halfdanarson (USA)
18:50 – 19:05 Discussion
-
- Arthur Braat (NED)
- Joachim Nilsson (SWE)
- Elisabetta Perrone (ITA)
- Thor Halfdanarson (USA)
19:05 – 19:10 Closing comments – Arthur Braat (NED)
Moderators:
Speakers:
